For example, given that HGSC is characterised by p53 mutations and accounts for the majority of high-grade ovarian tumours, it would be of interest to identify which cohorts of patients carry a p53 mutation and subsequently have a higher expression of CIP2A. The gene discussed is TP53; the disease is ovarian neoplasm.